Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin B6 (as pyridoxine or its active form, pyridoxal 5'-phosphate) has been studied for the management of premenstrual syndrome (PMS), including PMS Type S, which is characterized by symptoms like swelling, bloating, and breast tenderness often attributed to fluid retention. The scientific rationale for using B6 centers on its role in neurotransmitter synthesis (notably serotonin and dopamine), as well as its involvement in steroid hormone modulation and possibly influencing aldosterone-mediated fluid retention.

Several clinical trials from the 1970s to the 1990s evaluated B6 for PMS, with doses ranging from 50-100 mg/day. Meta-analyses, such as the one by Wyatt et al. (BMJ, 1999), suggest that B6 may have a modest benefit over placebo in reducing overall PMS symptoms, but methodological limitations, such as small sample sizes and inconsistent diagnostic criteria, make firm conclusions difficult. Evidence specifically for PMS Type S (fluid retention symptoms) is less robust, though some studies reported improvement in bloating and breast tenderness.

Current guidelines (e.g., ACOG) mention B6 as a possible option, with the caveat that evidence quality is low to moderate and high doses may carry risk of neuropathy. Thus, while there is scientific investigation and some supportive evidence, the overall strength is moderate at best, with further high-quality studies needed. The use of B6 for PMS Type S is scientifically explored but not definitively established.

More about Vitamin B6 (pyridoxine 5-phosphate)
More about PMS Type S

Other ingredients used for PMS Type S

Other health conditions supported by Vitamin B6 (pyridoxine 5-phosphate)

Products containing Vitamin B6 (pyridoxine 5-phosphate)